BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10428648)

  • 1. Analysis of the mode of action of a novel immunosuppressant FTY720 in mice.
    Luo ZJ; Tanaka T; Kimura F; Miyasaka M
    Immunopharmacology; 1999 Apr; 41(3):199-207. PubMed ID: 10428648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a novel immunosuppressant, FTY720, in mice without secondary lymphoid organs.
    Sugito K; Koshinaga T; Inoue M; Ikeda T; Hagiwara N; Fukuzawa M
    Surg Today; 2005; 35(8):662-7. PubMed ID: 16034547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L-positive T cells in Peyer's patches by FTY720-induced lymphocyte homing.
    Yanagawa Y; Masubuchi Y; Chiba K
    Immunology; 1998 Dec; 95(4):591-4. PubMed ID: 9893050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.
    Chiba K; Yanagawa Y; Masubuchi Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y
    J Immunol; 1998 May; 160(10):5037-44. PubMed ID: 9590253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that FTY720 induces T cell apoptosis in vivo.
    Nagahara Y; Enosawa S; Ikekita M; Suzuki S; Shinomiya T
    Immunopharmacology; 2000 Jun; 48(1):75-85. PubMed ID: 10822091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel immunosuppressant, FTY720, induces peripheral lymphodepletion of both T- and B cells and immunosuppression in baboons.
    Quesniaux V; Fullard L; Arendse H; Davison G; Markgraaff N; Auer R; Ehrhart F; Kraus G; Schuurman HJ
    Transpl Immunol; 1999 Sep; 7(3):149-57. PubMed ID: 10608298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
    Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
    Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.
    Pinschewer DD; Ochsenbein AF; Odermatt B; Brinkmann V; Hengartner H; Zinkernagel RM
    J Immunol; 2000 Jun; 164(11):5761-70. PubMed ID: 10820254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells.
    Kimura T; Hasegawa T; Nakai H; Azuma T; Usui N; Sasaki T; Okada A
    Transplantation; 2003 May; 75(9):1469-74. PubMed ID: 12792499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches.
    Halin C; Scimone ML; Bonasio R; Gauguet JM; Mempel TR; Quackenbush E; Proia RL; Mandala S; von Andrian UH
    Blood; 2005 Aug; 106(4):1314-22. PubMed ID: 15870184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD.
    Quesniaux VF; Menninger K; Kunkler A; Vedrine C; Bernhard M; Hedinger R; Kraus G; Schuurman HJ
    Transpl Immunol; 2000 Nov; 8(3):177-87. PubMed ID: 11147698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of timing of FTY720 administration on the immunosuppressive effect to prolong rat skin allograft survival.
    Yanagawa Y; Hoshino Y; Chiba K
    Int J Immunopharmacol; 2000 Aug; 22(8):597-602. PubMed ID: 10988354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
    J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel immunosuppressant, FTY720, increases the efficiency of a superantigen-induced peripheral T-cell deletion whilst inhibiting negative selection in the thymus.
    Shimizu C; Li X; Kimura M; Hashimoto K; Sugaya K; Kubo M; Suzuki S; Nakayama T
    Immunology; 1998 Aug; 94(4):503-12. PubMed ID: 9767438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression.
    Brinkmann V; Chen S; Feng L; Pinschewer D; Nikolova Z; Hof R
    Transplant Proc; 2001; 33(1-2):530-1. PubMed ID: 11266942
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
    Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720.
    Enosawa S; Suzuki S; Kakefuda T; Li XK; Amemiya H
    Immunopharmacology; 1996 Sep; 34(2-3):171-9. PubMed ID: 8886861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease.
    Hashimoto D; Asakura S; Matsuoka K; Sakoda Y; Koyama M; Aoyama K; Tanimoto M; Teshima T
    Eur J Immunol; 2007 Jan; 37(1):271-81. PubMed ID: 17154260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.